Treatment of persistent/recurrent nodal disease in nasopharyngeal cancer

Curr Opin Otolaryngol Head Neck Surg. 2021 Apr 1;29(2):86-92. doi: 10.1097/MOO.0000000000000687.

Abstract

Purpose of review: Persistent or recurrent disease in the neck lymphatics is an unusual pattern of failure in nasopharyngeal carcinoma (NPC) after definitive radiotherapy or chemoradiotherapy. The purpose of this review is to critically synthesize the current knowledge regarding salvage treatment of this unique form of failure in NPC.

Recent findings: Surgery in the form of radical neck dissection has been established as the standard salvage treatment with 5-year regional control of 60--86%. Recent shift in paradigm has resulted in the use of modified or selective neck dissection as salvage surgery in some centers. Risk factors for poor survival outcome include recurrent nodal disease, number of involved lymph nodes, extracapsular extension, high lymph node ratio, and positive resection margin. There are no well controlled studies on the role of additional radiotherapy or chemotherapy to improve local control or survival after salvage neck dissection in this group of patients with regional failure.

Summary: There is limited literature regarding the extent of surgical dissection in treating nodal persistent or recurrent disease. Prospective studies are also needed to determine whether adjuvant therapy improves treatment outcomes.

Publication types

  • Review

MeSH terms

  • Humans
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Neoplasms* / surgery
  • Neck Dissection
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Staging
  • Prospective Studies
  • Retrospective Studies
  • Salvage Therapy
  • Treatment Outcome